Semaglutide Weight Loss Program

Unfortunately, we do not accept insurance for the weight loss program at this time.

To schedule a Telehealth or in-office visit, you can click on the Book An Appointment, or call us at (954)526-2686.

Semaglutide is dispensed by our contracted pharmacy. If our office is selected as the final delivery destination, Semaglutide will arrive within 4-5 business days. If home delivery is selected, Semaglutide will arrive within 7-10 business days.

It typically takes about two weeks for Semaglutide to start working in the body. While taking Semaglutide, some people begin to see results within the first eight weeks, but most begin to see results within 12 weeks.

Clinical trials have shown that study participants taking a weekly dose of Semaglutide had an average reduction in body weight of 5-10 percent. This means that if you take Semaglutide for a year or more, you may experience up to 15 percent total weight loss.

A medical study of 1961 participants demonstrated that in a 68-week period, participants lost an average body weight of approximately 15%. Furthermore, 1 out of 3 participants lost more than 20% of their body weight.

1. Given the prior evidence and the results reported by Bezin et al. in this issue of Diabetes Care, it is possible that GLP-1 RAs cause a moderate relative increase in thyroid cancer, but detection bias cannot be ruled out as an alternative explanation. Thyroid cancer is a rare outcome, however, and the potential increase in absolute risk is very small.
2. Clinicians and patients need to always balance the benefit and harm of treatments in light of their alternatives.
3. In a population without specific risk factors for thyroid cancer, the benefits of GLP-1 RAs will largely outweigh the harm.

As part of a good weight reduction program and to prevent you from regaining the lost weight you will need to make changes to your day-to-day lifestyle. This includes modifying what you eat.

A good food program creates a healthy, sustainable way of eating that promotes weight loss and sets you up for long-term health. A good program does this by focusing on the quality of foods and making sure your body is getting the building blocks it needs while helping you to feel in-control.

Importantly, this food program is not a diet: We do not use meal replacements or meal plans. We don’t try to restrict your eating. Instead, we will help you rebalance your mindset into a new eating lifestyle.

The potential risk is of thyroid cancer which is already clearly identified in the drug insert.

Semaglutide is part of a class of medications called GLP-1 receptor agonists, or glucagon-like peptide-1 receptor agonists. It increases insulin secretion, which is good for diabetes. But at higher doses, it acts on centers in the brain and suppresses appetite. It is important to use this medication in conjunction with lifestyle intervention. What this medicine does is help patients adhere to a reduced-calorie diet. With obesity, you always need lifestyle changes plus the medicine.”

A safety signal does not necessarily imply a direct causal relationship between a medicine and the reported adverse event.

An assessment is to be initiated to further investigate whether there exists an indication of cause (a link) exists between the medication and the reported adverse event.

Semaglutide, and other drugs in the same category (glucagon-like peptide GLP-1 receptor antagonists), have been available in the market for over a decade. This is according to Andersen-Lange, Novo Nordisk’s products.

Additionally, the safety data gathered from clinical trials and post marketing surveillance have not shown any conclusive evidence linking them to thyroid cancer.

In order to minimize the strong feelings of hunger, our program includes a reverse titration schedule as well. This will help reduce the feelings of hunger and allow time to modify your diet for optimal satiation.

Additional visits to Reflections you will review what is working and what needs to change. You’ll discus some new menu options as well. This will also help reinforce your new eating habits and tweak any changes to help you.

If you miss a dose and the next scheduled dose is more than 2 days away, take the missed dose as soon as possible. If you miss a dose and the next scheduled dose is less than 2 days away, do not take the missed dose. Take the next dose at your regular time. Do not take double or extra doses. If you miss your dose for 2 weeks or more, take the next dose at your regular time or call your care team to talk about how to restart this medication.

We do not offer refunds for orders placed, goods received, and/or services rendered.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, reducing your sense of hunger, prescribed as an adjunct to a healthy diet and exercise regimen for weight loss and management.

Semaglutide can be administered weekly, at any time of day but it should be on the same day each week, with or without meals.

The maintenance dose of Semaglutide is 2.4 mg once weekly.  This dosage is met gradually under the direction of your medical provider.

Your provide will go over interactions as part of your initial consultation. Medications for diabetes are on the list as well as others listed in the full disclosure form.

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

1. Obesity is a known factor.
2. Over diagnosis of thyroid cancer.
3. More research is needed to differentiate the causal relationship.

Your provider will review the information sheet which provides full disclosure of known side effects and conditions that would exclude you from getting this treatment. A partial list includes:

• Endocrine tumors (MEN 2) or if someone in your family had these tumors
• Eye disease, vision problems
• Gallbladder disease
• History of depression or mental health disease
• History of pancreatitis
• Kidney disease
• Stomach or intestine problems
• Suicidal thoughts, plans, or attempt; a previous suicide attempt by you or a family member
• Thyroid cancer or if someone in your family had thyroid cancer
• An unusual or allergic reaction to Semaglutide, other medications, foods, dyes, or preservatives
• Pregnant or trying to get pregnant
• Breast-feeding

Attend your scheduled visits with your provider for regular checks on your progress. It may be some time before you see the benefit from this medication.

Be sure to drink plenty of fluids while taking this medication. If you have severe diarrhea, nausea, and vomiting, or if you sweat a lot check in with your provider. The loss of too much body fluid may make it dangerous for you to take this medication.

This medication may affect blood sugar levels. Ask your provider if changes in diet or medications are needed if you have diabetes.

If you or your family notice any changes in your behavior, such as new or worsening depression, thoughts of harming yourself, anxiety, other unusual or disturbing thoughts, or memory loss, call your provider right away.

Losing weight while pregnant is not advised and may cause harm to the unborn child. Talk to your care team for more information .Women should inform their care team if they wish to become pregnant or think they might be pregnant

Side effects tend to come on early in the course of treatment and get better over time. Only infrequently are they serious enough that patients have to stop taking the drug. In practice with the dosage plan, you build up gradually to overcome symptoms. The side effects that you should report to your provider as soon as possible include:

• Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
• Change in vision
• Dehydration—increased thirst, dry mouth, feeling faint or lightheaded, headache, dark yellow or brown urine
• Gallbladder problems—severe stomach pain, nausea, vomiting, fever
• Heart palpitations—rapid, pounding, or irregular heartbeat
• Kidney injury—decrease in the amount of urine, swelling of the ankles, hands, or feet
• Pancreatitis—severe stomach pain that spreads to your back or gets worse after eating or when touched, fever, nausea, vomiting
• Thoughts of suicide or self-harm, worsening mood, feelings of depression
• Thyroid cancer—new mass or lump in the neck, pain or trouble swallowing, trouble breathing, hoarseness

Side effects that usually do not require medical attention (report to your provider if they continue or are bothersome):

• Diarrhea
• Loss of appetite
• Nausea
• Stomach pain
• Vomiting

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

If there is a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MENS2) or in case of hypersensitivity to Semaglutide.

Semaglutide should be injected subcutaneously into upper arms, abdomen or thighs.

There are three qualifying categories:

1. Adults with a BMI of 30 or more (obesity category).
2. Adults with a BMI of 27-29 (overweight category), who also have at least one weight-related comorbid condition such as hypertension, diabetes type 2, or hyperlipidedemia.
3. Pediatrics, 12 years and older with a BMI in the 95th percentile or greater.